EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal Characterization of APOE ε4‐Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease

Haoran Cheng iD, Huwei Xia, Youjie Wang iD, Le Cao iD, Suqing Hu, Huayan Wang, William Robert Kwapong iD, Zhen Wang iD, Caiyun Wen

CNS Neuroscience & Therapeutics · 2026-10 · 32 (10)

DOI: 10.1002/cns.71220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 24.10.2026. Verfasst von Haoran Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4, Retinal Vessels, Retina. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biological heterogeneity remains a major challenge in Alzheimer's disease (AD), even among individuals with biomarker‐confirmed disease. The apolipoprotein E (APOE) ε4 allele is associated with greater amyloid burden, neurodegeneration, and vascular dysfunction. We investigated whether retinal microvascular imaging provides complementary information beyond plasma and neuroimaging biomarkers for characterizing APOE ε4‐associated neurovascular heterogeneity in biologically defined AD.

Methods

Eighty‐four amyloid‐positive patients with AD underwent color fundus photography, swept‐source optical coherence tomography angiography (OCTA), plasma biomarker assessment, amyloid positron emission tomography, and magnetic resonance imaging. Retinal vascular parameters were compared between APOE ε4 carriers and non‐carriers using generalized estimating equations. Candidate multimodal biomarkers were identified using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to evaluate the incremental contribution of retinal biomarkers within a multimodal phenotyping model.

Results

Compared with non‐carriers, APOE ε4 carriers demonstrated significantly lower retinal superficial vascular complex (SVC) and deep vascular complex densities, reduced retinal vascular fractal dimension, higher amyloid PET standardized uptake value ratios, increased peak width of skeletonized mean diffusivity, and smaller hippocampal volumes (all p < 0.05). Following penalized feature selection, retinal SVC density remained independently associated with APOE ε4 status alongside amyloid burden, hippocampal volume, and white matter microstructural injury. Incorporation of SVC modestly improved discrimination and calibration of the multimodal model compared with neuroimaging biomarkers alone.

Conclusions

Retinal microvascular alterations are associated with APOE ε4‐related biological heterogeneity in biomarker‐confirmed AD. Retinal vascular imaging provides complementary information beyond established plasma and neuroimaging biomarkers and may enhance multimodal characterization of neurovascular phenotypes rather than serve as a surrogate for genetic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseApolipoprotein E4Retinal VesselsRetinaHumansFemaleMaleBiomarkersAgedNeuroimagingPositron-Emission TomographyMultimodal ImagingMagnetic Resonance ImagingTomography, Optical CoherenceAged, 80 and over

Stichwörter der Autor:innen

APOE ε4Alzheimer's diseasePSMDamyloid PETmultimodal biomarkersneurovascular dysfunctionretinal imaging

Substanzen

Apolipoprotein E4Biomarkers

Autor:innen und Institutionen

  • Department of Geriatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Neurology, Sir Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
  • Neurology Department, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Haoran Cheng, Youjie Wang, Le Cao, William Robert Kwapong, Zhen Wang

Zitieren

APA

Cheng, H., Xia, H., Wang, Y., Cao, L., Hu, S., Wang, H., Kwapong, W. R., Wang, Z., & Wen, C. (2026). Multimodal Characterization of APOE ε4‐Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease. CNS Neuroscience & Therapeutics, 32(10). https://doi.org/10.1002/cns.71220

Vancouver

Cheng H, Xia H, Wang Y, Cao L, Hu S, Wang H, et al. Multimodal Characterization of APOE ε4‐Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease. CNS Neuroscience & Therapeutics. 2026;32(10). doi:10.1002/cns.71220

BibTeX
@article{Cheng2026,
  author = {Cheng, Haoran and Xia, Huwei and Wang, Youjie and Cao, Le and Hu, Suqing and Wang, Huayan and Kwapong, William Robert and Wang, Zhen and Wen, Caiyun},
  title = {Multimodal Characterization of APOE ε4‐Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {10},
  doi = {10.1002/cns.71220}
}
Kostenlos starten →